Emmes

Emmes

Emmes is a clinical research collaborator.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

N/A

Buyout
Total Funding000k
More about Emmes
Made with AI
Edit

Emmes is a global contract research organization (CRO) specializing in managing clinical research studies for biopharmaceutical companies and public health organizations. The company offers a wide range of services including biostatistics, clinical data management, clinical trial management, endpoint solutions, global regulatory affairs, pharmacovigilance, and medical monitoring. Emmes operates in the biopharmaceutical and public health markets, providing expertise in various therapeutic areas.

Emmes' business model revolves around offering end-to-end clinical research services, from study design to data analysis and regulatory submissions. The company generates revenue through service contracts with its clients, who rely on Emmes' specialized skill sets and technologies to advance their clinical research projects. Emmes leverages workflow automation, AI-assisted analysis, and real-world evidence to enhance the quality and efficiency of its services.

Clients benefit from Emmes' agile and collaborative approach, which ensures that clinical research is managed with precision and dedication. The company is committed to adhering to data privacy frameworks, ensuring the protection of personal data in compliance with international standards.

Keywords: Clinical Research, Biostatistics, Data Management, Regulatory Affairs, Pharmacovigilance, Medical Monitoring, Public Health, Biopharmaceutical, AI Analysis, Workflow Automation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Emmes

Edit
Orphan Reach
ACQUISITION by Emmes May 2021
Institut Dr. Schauerte
ACQUISITION by Emmes Dec 2021
Clinical Edge
ACQUISITION by Emmes Sep 2022
Essex Management
ACQUISITION by Emmes Mar 2023
VaxTRIALS
ACQUISITION by Emmes Oct 2023